Aromasin and Marinol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aromasin (exemestane) and Marinol (dronabinol). Common drug interactions include constipation among females.

The phase IV clinical study analyzes what interactions people have when they take Aromasin and Marinol. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Aromasin?

Aromasin has active ingredients of exemestane. It is often used in breast cancer. eHealthMe is studying from 12,863 Aromasin users. Check the latest studies of Aromasin.

What is Marinol?

Marinol has active ingredients of dronabinol. It is often used in pain. eHealthMe is studying from 4,963 Marinol users. Check the latest studies of Marinol.



On Jul, 28, 2026

19 people who take Aromasin and Marinol together, and have interactions are studied.

Aromasin and Marinol drug interactions.

What are the common drug interactions of Aromasin and Marinol, by gender? *:

female:

  1. Constipation
  2. Cough
  3. Cranial nerve disorder (impaired functioning of one of the twelve cranial nerves)
  4. Cyst (a closed sac)
  5. Dental care
  6. Dysphagia (a condition in which swallowing is difficult or painful)
  7. Dyspnoea exertional (breathlessness or shortness of breath)
  8. Ear pain
  9. Emotional disorder
  10. Eustachian tube dysfunction (eustachian tube problems like clearing the ears when flying, suffering infection, and recurring ear infection)

male:

n/a

What are the common drug interactions of Aromasin and Marinol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  2. Fatigue (feeling of tiredness)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  5. Oedema peripheral (superficial swelling)
  6. Renal atrophy (wasting of kidney)
  7. Urinary retention (the inability to completely or partially empty the bladder)
  8. Lung neoplasm (tumour of lung)
  9. Lymphadenopathy mediastinal (an enlargement of the lymph nodes in the part of the chest that separates the lungs)
  10. Device related infection

50-59:

  1. Abdominal pain lower
  2. Asthenia (weakness)
  3. Abdominal pain
  4. Acne (skin problems that cause pimples)
  5. Death
  6. Dermatitis diaper (diaper rash is a common form of inflamed skin)
  7. Drug ineffective
  8. Erythema (redness of the skin)
  9. Hepatic pain (pain in liver)
  10. Insomnia (sleeplessness)

60+:

  1. Disease progression

What are the existing conditions these people have? *

  1. Breast Cancer Metastatic: 10 people, 52.63%
  2. Metastases To Bone (cancer spreads to bone): 9 people, 47.37%
  3. Stomatitis (inflammation of mucous membrane of mouth): 3 people, 15.79%
  4. Nausea (feeling of having an urge to vomit): 3 people, 15.79%
  5. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 5.26%
  6. Breast Cancer Female: 1 person, 5.26%
  7. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Aromasin and Marinol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Aromasin and Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aromasin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Marinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Aromasin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Marinol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on exemestane and dronabinol (the active ingredients of Aromasin and Marinol, respectively), and Aromasin and Marinol (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: